Archived: 7th Winter Conference
on Medicinal & Bioorganic Chemistry

February 26th - March 1st 2006

Sheraton Sand Key Resort, Florida


Sunday, February 26th 2006

Medicinal Chemistry for Bio-Defense

Program Chair: Wayne Brouillette, University of Alabama – Birmingham / Lester A. Mitscher, University of Kansas

Gerry Wright McMaster University Bad Bugs

Good Bugs. What’s the Difference?

Lutz Tautz Burnham Institute for Medical Research

Novel Tyrosine Phosphatase Inhibitors for Treatment of Yersinia Infections

Michael Pirrung University of California

Riverside Smallpox as a Novel Drug Target

Daniel H. Rich University of Wisconsin at Madison Rational Drug Design

Where it has been and where might it go in the 21st Century

Monday, February 27th 2006

Recent Advances in Organic Chemistry Methodology

Program Chair: Albert Padwa, Emory University

Lanny Liebeskind Emory University

Metals Methods, and Molecules

Frank McDonald Emory University

Biomimetic Synthesis via Polyepoxide Cyclizations

Justin Gallivan Emory University

Genetic Screens and Selections for Small Molecules

Stefan Lutz Emory University

Tailoring Biocatalysts for Enantioselective Synthesis

Dennis Liotta Emory University

New Therapies for Treating Viral Diseases and Cancers

General Oral Papers I

Program Chair: John Dodd, Bristol-Meyers Squibb

Robert Fecik University of Minnesota

Synthesis and Evaluation of Thioesterase Affinity Labels

Courtney Aldrick University of Minnesota

Rationally Designed Antibiotics That Inhibit Siderophore Biosynthesis of Mycobacterium tuberculosis

Apurba Dutta University of Kansas

Stereoselective Routes to Bioactive Heterocycles: An AminoAcid Chiral Template Approach

Thomas Rϋckle Serono Pharmaceutical Research Institute

Furan-2-glmethylene-Azolidine-Diones as novel, potent and selective inhibitors of Phosphoinositide 3-Kinase g

Scott D. Edmondson Merck and Company Inc.

Discovery of a potent, orally active Phenylalanine Derived Dipeptidyl Peptidase IV Inhibitor for the treatment of Type 2 Diabetes

Poster Session

Program Chair: Jack Hodges, Berry and Associates

Not Itemized

Wednesday, March 1st 2006

Young Investigators in Organic Synthesis

Program Chair: Michael VanNieuwenhze, University of California - San Diego

Michael VanNieuwenhze University of California - San Diego

Synthesis and Study of Cyclic Depsipeptides that Inhibit Bacterial Cell Wall Biosynthesis

Dirk Trauner University of California - Berkeley

Development of Photoactivated Glutamate Receptors and Other Studies in Total Synthesis

Melanie Sanford University of Michigan

Synthetic Applications and Mechanistic Investigations of Directed C–H Bond Oxidation

Helen E. Blackwell University of Wisconsin

Modulation of Bacterial Communication Pathways with Synthetic Ligands

James Henry Eli Lilly & Company Design

Synthesis and Discovery of a Novel Multi-targeted Anti-angiogenic Kinase Inhibitor (MAK)

Media Sponsors